Ms Hill is an experienced non-executive director of ASX-listed companies with expertise at board level in technology, biotech, and medical device sectors. She also has experience with international listing exchanges, including Nasdaq (US) and AIM (UK). Prior to her board career, Kate spent more than 20 years as an audit partner at Deloitte, serving both ASX-listed and privately owned clients. Over the past three years, Kate has held board positions with several listed companies, including Count Limited where she serves as Independent Non-Executive Director, Chair of the Audit & Risk Committee, and a member of the Acquisitions Committee. She also serves as Chair of Seeing Machines Limited and is a member of the Finance & Risk Committee and the People, Culture & Remuneration Committee. At Adheris Health, prior to 1 December 2025, Kate has been Independent Non-Executive Director and Chair since 1 April 2025 and is a member of the Remuneration & Nominations Committee. In addition, she serves as Independent Non-Executive Director and Chair of the Audit & Risk Committee at hipages Group Holdings Limited.
